This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03206/identifier/pubchem-substance/
n16http://linked.opendata.cz/resource/mesh/concept/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03206/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n15http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03206/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03206/identifier/bindingdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03206/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03206
rdf:type
n5:Drug
n5:description
An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. [PubChem]
n5:group
experimental
owl:sameAs
n4:DB03206 n7:DB03206
dcterms:title
1-Deoxynojirimycin
adms:identifier
n10:46507744 n11:NOJ n12:44387838 n13:18351 n14:DB03206
n5:synonym
NOJ DNJ 1,5-Dideoxy-1,5-imino-D-glucitol 1,5-Deoxy-1,5-imino-D-mannitol 1-Deoxymannojirimycin 1-Deoxy-Nojirimycin DNM
n5:toxicity
ORL-RAT LD<sub>50</sub>: &gt; 5g/kg.
n5:synthesisReference
Theo Schroder, Mathias Stubbe, "Process for preparing 1-deoxynojirimycin and N-derivatives thereof." U.S. Patent US4806650, issued September, 1986.
n15:hasConcept
n16:M0026526
n5:IUPAC-Name
n6:271B595F-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5965-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5964-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5961-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5962-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5963-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B595D-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B595B-363D-11E5-9242-09173F13E4C5 n6:271B595E-363D-11E5-9242-09173F13E4C5 n6:271B5975-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B595C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B596B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B596C-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5966-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5967-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5969-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5968-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B596A-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
19130-96-2
n5:category
n5:Bioavailability
n6:271B5971-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5973-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5974-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5970-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B596F-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5972-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5960-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B596D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B596E-363D-11E5-9242-09173F13E4C5